T

Theragen Etex Co Ltd
KOSDAQ:066700

Watchlist Manager
Theragen Etex Co Ltd
KOSDAQ:066700
Watchlist
Price: 2 765 KRW -4.49%
Market Cap: 102.7B KRW

Operating Margin

5.1%
Current
Declining
by 0.2%
vs 3-y average of 5.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.1%
=
Operating Income
₩13.7B
/
Revenue
₩268.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.1%
=
Operating Income
₩13.7B
/
Revenue
₩268.1B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Theragen Etex Co Ltd
KOSDAQ:066700
101.4B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Korea
Percentile
64rd
Based on 2 615 companies
64rd percentile
5.1%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Theragen Etex Co Ltd
Glance View

Market Cap
102.7B KRW
Industry
Pharmaceuticals

THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. The company is headquartered in Ansan, Gyeonggi-Do. The company went IPO on 2004-05-27. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The firm operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.

Theragen Etex Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.1%
=
Operating Income
₩13.7B
/
Revenue
₩268.1B
What is Theragen Etex Co Ltd's current Operating Margin?

The current Operating Margin for Theragen Etex Co Ltd is 5.1%, which is below its 3-year median of 5.3%.

How has Operating Margin changed over time?

Over the last 3 years, Theragen Etex Co Ltd’s Operating Margin has increased from 2.3% to 5.1%. During this period, it reached a low of 2.3% on Aug 30, 2022 and a high of 6.2% on Dec 31, 2022.

Back to Top